Macropinocytosis-Inducible Extracellular Vesicles Modified with Antimicrobial Protein CAP18-Derived Cell-Penetrating Peptides for Efficient Intracellular Delivery.
Kosuke NoguchiMomoko ObukiHaruka SumiMerlin KlußmannKenta MorimotoShinya NakaiTakuya HashimotoDaisuke FujiwaraIkuo FujiiEiji YubaTomoka Takatani-NakaseInes NeundorfIkuhiko NakasePublished in: Molecular pharmaceutics (2021)
The antimicrobial protein CAP18 (approximate molecular weight: 18 000), which was first isolated from rabbit granulocytes, comprises a C-terminal fragment that has negatively charged lipopolysaccharide binding activity. In this study, we found that CAP18 (106-121)-derived (sC18)2 peptides have macropinocytosis-inducible biological functions. In addition, we found that these peptides are highly applicable for use as extracellular vesicle (exosomes, EV)-based intracellular delivery, which is expected to be a next-generation drug delivery carrier. Here, we demonstrate that dimerized (sC18)2 peptides can be easily introduced on EV membranes when modified with a hydrophobic moiety, and that they show high potential for enhanced cellular uptake of EVs. By glycosaminoglycan-dependent induction of macropinocytosis, cellular EV uptake in targeted cells was strongly increased by the peptide modification made to EVs, and intriguingly, our herein presented technique is efficiently applicable for the cytosolic delivery of the biologically cell-killing functional toxin protein, saporin, which was artificially encapsulated in the EVs by electroporation, suggesting a useful technique for EV-based intracellular delivery of biofunctional molecules.
Keyphrases
- amino acid
- drug delivery
- single cell
- protein protein
- reactive oxygen species
- staphylococcus aureus
- binding protein
- escherichia coli
- cell therapy
- stem cells
- cancer therapy
- toll like receptor
- risk assessment
- cell death
- dna binding
- transcription factor
- climate change
- lps induced
- oxidative stress
- endoplasmic reticulum stress
- bone marrow